TrialScope | Unsubscribe

Presented by:

Jo Anne-Marie Blyskal

Head of Global Regulatory Medical Writing & Data Transparency and Disclosure Groups Teva Pharmaceuticals

JMary Lou Tomson

Senior Director of Clinical Operations Lung Biotechnology

Matt DeFranco

Director of Solution EngineeringTrialScope

In this webinar, you’ll hear why Teva and Lung Biotechnology opted for Disclosure as a Service and how it helps them conquer the complexities of clinical trial disclosure by:

Outsourcing all or parts of the disclosure management process
Broadening the bandwidth of the disclosure team
Safeguarding regulatory compliance and mitigating risk
Developing disclosure expertise and future-proofing their operations

Nobody said trial disclosure was easy – but it is a regulatory requirement and an important part of your commitment to transparency. Regardless of the size of your trial portfolio, managing clinical trial disclosure can pose daily challenges. Resources may be stretched thin, rules are complex, and data sets span different registries and requirements.

The clinical trial disclosure world moves fast. To keep up, you need a partner that keeps you ahead of changing regulations and evolving transparency expectations. Disclosure Management Software can do amazing things for elevating your clinical trial disclosure efforts. But in some cases, there’s simply no substitute for leaning on those who understand clinical trial transparency — and the technology that supports it — inside and out.

Unsubscribe from TrialScope

Presented by:

Jo Anne-Marie Blyskal

JMary Lou Tomson

Matt DeFranco